These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4843281)

  • 1. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial of bilopaque (tyropanoate sodium) oral cholecystography. Evaluation of time for the optimal and peak opacification of the gallbladder.
    Han SY; Witten DM
    Radiology; 1974 Sep; 112(3):529-30. PubMed ID: 4843280
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study of four oral cholecystographic preparations.
    Parks RE
    Radiology; 1974 Sep; 112(3):525-8. PubMed ID: 4602064
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of fasting on gallbladder opacification during oral cholecystography: a controlled study in normal volunteers.
    Loeb PM; Berk RN; Janes JO; Perkin L; Moore J
    Radiology; 1978 Feb; 126(2):395-401. PubMed ID: 341220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of oral cholecystopaques: iopronic acid vs. iopanoic acid.
    Amberg JR; Goldberger LA; Bates M
    Radiology; 1980 Jan; 134(1):31-2. PubMed ID: 6985742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral cholecystography in the early phase of acute alcoholic pancreatitis. A prospective, randomized comparison of Telepaque and Bilopaque.
    Smith HJ; Corbett DB; Loeb PM; Peterson WL
    Invest Radiol; 1982; 17(6):629-33. PubMed ID: 6759457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The choleretic action of sodium tyropanoate (bilopaque sodium) in the dog: preliminary observation.
    Nelson JA; Straubus AE; Amberg JR
    Invest Radiol; 1974; 9(6):438-43. PubMed ID: 4430583
    [No Abstract]   [Full Text] [Related]  

  • 11. Gallbladder density and iodine concentration in humans during oral cholecystography. A comparison of iopanoic acid and iopronic acid.
    Thompson WM; Meyers WC; Shaw M; Bates M; Johnson GA; Hedlund LW
    Invest Radiol; 1982; 17(6):621-8. PubMed ID: 6759456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new contrast agent for oral cholecystography: iopronic acid (Oravue).
    Pizzolato NF; Arcomano JP; Baum AE
    AJR Am J Roentgenol; 1978 May; 130(5):845-7. PubMed ID: 417581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The uricosuric effect of bilopaque (sodium tyropanoate). A contribution to the problem of nephro-toxicity of oral biliary contrast media].
    Burgener FA; Fischer HW
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Dec; 117(6):685-8. PubMed ID: 4346201
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent triiodinated contrast media for oral cholecystocholangiography].
    Sviridov NK; Popova ZP; Varfolomeeva VN
    Med Radiol (Mosk); 1985 Feb; 30(2):58-60. PubMed ID: 3155821
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical trial of oral cholecystography using combinations of contrast agents and two consecutive doses.
    Thoeni RF; Moss AA
    Radiology; 1982 Jul; 144(2):271-5. PubMed ID: 7045975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TYROPANOATE SODIUM. A NEW ORAL CHOLECYSTOGRAPHIC MEDIUM.
    DAVIS JJ
    Rocky Mt Med J; 1964 Apr; 61():35-9. PubMed ID: 14137928
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of three cholecystographic agents. A double-blind study with and without a prior fatty meal.
    Stanley RJ; Melson GL; Cubillo E; Hesker AE
    Radiology; 1974 Sep; 112(3):513-7. PubMed ID: 4602063
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiographic appearance of the nonabsorbed (unconjugated) and conjugated sodium tyropanoate (Bilopaque) in the bowel.
    Muhletaler CA; Gerlock AJ; Amberg JR; Avant GR
    Invest Radiol; 1982; 17(5):506-9. PubMed ID: 7141832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of iocetamic acid and sodium iopodate in cholecystography.
    Golberg B
    Radiol Clin (Basel); 1977; 46(1):42-9. PubMed ID: 136669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid.
    Berk RN; Loeb PM; Cobo-Frenkel A; Barnhart JL
    Invest Radiol; 1977; 12(1):85-95. PubMed ID: 838560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.